Lemborexant Patent Expiration
Lemborexant is Used for treating insomnia in adults with difficulties in sleep onset and/or sleep maintenance. It was first introduced by Eisai Inc
Lemborexant Patents
Given below is the list of patents protecting Lemborexant, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Dayvigo | US10188652 | Compositions and methods for treating insomnia | Oct 21, 2035 | Eisai Inc |
| Dayvigo | US10702529 | Compositions and methods for treating insomnia | Oct 21, 2035 | Eisai Inc |
| Dayvigo | US11026944 | Compositions and methods for treating insomnia | Oct 21, 2035 | Eisai Inc |
| Dayvigo | US8268848 | Cyclopropane compound | Sep 20, 2031 | Eisai Inc |
Lemborexant's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List